BridgeBio Pharma Inc (BBIO)
24.10
-0.69
(-2.78%)
USD |
NASDAQ |
Nov 14, 16:00
24.10
0.00 (0.00%)
After-Hours: 17:27
BridgeBio Pharma Total Return Level: 24.79 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 24.79 |
November 12, 2024 | 24.62 |
November 11, 2024 | 26.12 |
November 08, 2024 | 27.09 |
November 07, 2024 | 25.88 |
November 06, 2024 | 25.61 |
November 05, 2024 | 25.52 |
November 04, 2024 | 25.20 |
November 01, 2024 | 25.48 |
October 31, 2024 | 23.41 |
October 30, 2024 | 23.79 |
October 29, 2024 | 24.50 |
October 28, 2024 | 24.44 |
October 25, 2024 | 23.84 |
October 24, 2024 | 24.17 |
October 23, 2024 | 24.45 |
October 22, 2024 | 24.94 |
October 21, 2024 | 25.16 |
October 18, 2024 | 26.02 |
October 17, 2024 | 26.19 |
October 16, 2024 | 26.34 |
October 15, 2024 | 25.38 |
October 14, 2024 | 25.78 |
October 11, 2024 | 25.90 |
October 10, 2024 | 24.96 |
Date | Value |
---|---|
October 09, 2024 | 23.38 |
October 08, 2024 | 24.73 |
October 07, 2024 | 24.84 |
October 04, 2024 | 25.23 |
October 03, 2024 | 25.63 |
October 02, 2024 | 25.08 |
October 01, 2024 | 24.80 |
September 30, 2024 | 25.46 |
September 27, 2024 | 24.94 |
September 26, 2024 | 24.48 |
September 25, 2024 | 24.51 |
September 24, 2024 | 24.86 |
September 23, 2024 | 25.40 |
September 20, 2024 | 26.74 |
September 19, 2024 | 26.83 |
September 18, 2024 | 25.96 |
September 17, 2024 | 26.73 |
September 16, 2024 | 26.19 |
September 13, 2024 | 26.18 |
September 12, 2024 | 26.95 |
September 11, 2024 | 27.99 |
September 10, 2024 | 29.99 |
September 09, 2024 | 30.70 |
September 06, 2024 | 30.70 |
September 05, 2024 | 31.30 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.21
Minimum
May 11 2022
72.35
Maximum
Feb 08 2021
30.06
Average
28.62
Median
Total Return Level Benchmarks
Alnylam Pharmaceuticals Inc | 264.47 |
Pfizer Inc | 95.41 |
Vertex Pharmaceuticals Inc | 494.61 |
PTC Therapeutics Inc | 44.05 |
Bristol-Myers Squibb Co | 239.89 |